This online course will give participants a practical introduction to the 21 CFR Part 11 regulations, which affects many aspects of computerized systems in the pharmaceutical industry. The course will present an overview of Part 11 expectations including FDA's current interpretation.This will be followed by a detailed analysis of Part 11 requirements, a discussion of electronic records and signatures, and key industry issues. The recently revised EU GMP Annex 11 and Chapter 4 (which have been adopted for international use by PIC/S) are also covered. As well as the European and international expectations for electronic records and signatures, the general requirements for computer systems validation and compliance as described in Annex 11 will be explained in detail.
Attendance suggested for:
Community of Practice (COP): This training course is of particular interest to existing and future members of the ISPE Containment Community of Practice (COP).
Sion Wyn is an acknowledged expert in computer system validation and compliance and international regulations in this field. He assisted the FDA with its re-examination of 21 CFR Part 11, and is a member of the team that produced the FDA Guidance on 21 CFR Part 11 Scope and Application. He is the technical content expert for the FDA's ORA Virtual University on-line training modules on computerized systems validation and compliance. He has received the FDA Group Recognition Award for work on Part 11. Wyn is the editor of ISPE's GAMP5 Guide - A Risk-Based Approach to Compliant GxP Computerized Systems and is a member of the ISPE GAMP Council, GAMP Editorial Board, and the GAMP Europe Steering Committee.